Gyre Therapeutics (GYRE) Net Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -4,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,759.00 |
| Dec 31, 2025 | 2,484.00 |
| Mar 31, 2025 | 184,296.00 |
| Dec 31, 2024 | 83,198.00 |
| Sep 30, 2024 | 110,219.00 |
| Jun 30, 2024 | 177,441.00 |
| Mar 31, 2024 | 155,724.00 |
| Dec 31, 2023 | 55,886.00 |
| Sep 30, 2023 | 180,782.00 |
| Jun 30, 2023 | 104,661.00 |
| Mar 31, 2023 | 3,377.00 |
| Mar 31, 2021 | 8.25 Mn |
| Dec 31, 2020 | 87,820.00 |
| Sep 30, 2020 | 2,629.00 |
| Jun 30, 2020 | 781,376.00 |
| Mar 31, 2020 | 150,217.00 |
| Mar 31, 2018 | -8.30 Mn |
| Dec 31, 2017 | -113,114.00 |
| Sep 30, 2017 | -93,322.00 |
| Jun 30, 2017 | -611,466.00 |
| Mar 31, 2017 | 352,323.00 |
| Dec 31, 2016 | 908,283.00 |
| Mar 31, 2016 | -306,730.00 |
| Dec 31, 2015 | -325,345.00 |
| Sep 30, 2015 | -228,785.00 |
| Jun 30, 2015 | -54,785.00 |
| Mar 31, 2015 | -101,465.00 |
| Dec 31, 2014 | -62,622.00 |
| Sep 30, 2014 | -84,072.00 |
| Jun 30, 2014 | -272,851.00 |
| Mar 31, 2014 | -508,245.00 |
| Dec 31, 2013 | -1.44 Mn |